Partners

  • Charité University Medicine Berlin, Germany
  • DCPrime, Netherlands
  • Diagnostik Netzwerk Berlin Brandenburg - DiagnostikNet | BB, Germany
  • Fasteris SA, Switzerland
  • Haukeland University Hospital, Helse Bergen, Norway
  • Medical University of Graz, Austria
  • Natural and Medical Sciences Institute (NMI) Reutlingen, Tumor Biology, Germany
  • NMI Natural and Medical Sciences Institute, University of Tübingen, Germany
  • Oceanbasis GmbH, Kiel, Germany
  • Sciospec Scientific Instruments GmbH, Bennewitz, Germany
  • Technical University (TU) Berlin, Germany
  • Technical University Vienna, Austria
  • Therycell GmbH, Berlin, Germany
  • THT Biomaterials GmbH, Vienna, Austria
  • University Clinics Schleswig-Holstein, Kiel, Germany
  • University Medical Clinic (UMC) Mainz, Department of Internal Medicine 3, Germany
  • University Hospital Essen (UKE), Germany
  • University Hospital Erlangen, Department of Internal Medicine 5 - Hematology/Oncology, Germany
  • UpNano GmbH, Vienna, Austria
  • Vivantes Clinic Neuköln, Berlin, Germany

 

HS Diagnomics GmbH

Schloßstrasse 110
12163 Berlin
Germany

Tel. +49(30)700 14 53 30
Fax +49(30)546 11 698

Customer Support
Tel. +49(30)700 14 53 31

HSDiagnomics

News

06/2024
Project Update: HS Diagnomics has entered into the international collaborative project ELEVATE with TU Wien, NMI Tübingen, Sciospec, UpNano, and THT Biomaterials
Read more ...

10/2023
HSDiagnomics partners with Charité University Medicine Berlin, TheryCell GmbH, and EPO GmbH in an innovative project to advance TCR-T therapy for solid tumors
Read more ...

06/2020
TCRsafe® analysis of a Runx1 knockout mouse model provides evidence for a role of RUNX1 as a recombinase cofactor for TCRß rearrangements and pathological deletions
Read more ...

08/2019
ZIM-Project TCR-specific Antigen Identification - TAgID
Read more ...

04/2018
Patent granted for the identification of tumor-specific T-cell receptors
Read more ...